We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PXMD market cap is 7.49M. The company's latest EPS is USD -1.6812 and P/E is -0.41.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.36M | -4.36M | -4.39M | -3.69M | -3M |
| Net Income | -3.49M | -5.05M | -5.92M | -3.69M | -3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -599k | -5.57M | -7.2M | -10.6M | -16.15M |
| Net Income | -599k | -9.3M | -10.23M | -14.8M | -18.29M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.14M | 3.23M | 5.68M | 2.89M | 800k |
| Total Liabilities | 2.88M | 3.77M | 2.3M | 1.7M | 2.61M |
| Total Equity | 2.27M | -537k | 3.39M | 1.19M | -1.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25k | 1.12M | 649k | 2.2M | 5.68M |
| Total Liabilities | 123k | 5.75M | 10.76M | 2.1M | 2.3M |
| Total Equity | -864k | -4.63M | -10.11M | 109k | 3.39M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.82M | -8.15M | -10.77M | -3.07M | -4.37M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 6.99M | 7.4M | 13.58M | -15k | -15k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -419k | -2.35M | -5.51M | -6.07M | -10.77M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 435k | 3.45M | 4.83M | 7.53M | 13.58M |
| Market Cap | 7.49M |
| Price to Earnings Ratio | -0.41 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.59 |
| Price to Book Ratio | 2.22 |
| Dividend Yield | - |
| Shares Outstanding | 10.88M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0.02%) |
| Company Name | PaxMedica Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
